스마트 인슐린 펜 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Smart Insulin Pens Market size is expected to reach USD 2523.70 Million in 2034 from USD 933.06 Million (2025) growing at a CAGR of 11.69% during 2026-2034.

The global smart insulin pens market has grown rapidly as digital health technologies transform diabetes management. Smart insulin pens are advanced devices that help patients administer insulin while tracking dosage, timing, and usage patterns. These devices often connect to mobile applications, allowing users and healthcare providers to monitor insulin administration more effectively. The increasing global prevalence of diabetes has significantly contributed to the demand for these innovative devices.

Several factors are driving market growth, including the rising need for improved diabetes management and patient adherence to insulin therapy. Smart insulin pens offer features such as dose reminders, automatic tracking, and data sharing with healthcare professionals. These capabilities help patients maintain better control over blood glucose levels and reduce the risk of dosing errors.

Looking forward, the smart insulin pens market is expected to benefit from continued advancements in digital healthcare technologies. Integration with continuous glucose monitoring systems and mobile health platforms may provide more comprehensive diabetes management solutions. Increasing healthcare awareness and expanding access to diabetes care in emerging markets will likely drive further adoption. As digital health solutions continue to evolve, smart insulin pens will remain an important tool in diabetes treatment.

MARKET SEGMENTATION

By Connectivity

• Bluetooth
• Near Field Communication (NFC)

By Indication

• Type 1 Diabetes
• Type 2 Diabetes

By Distribution Channel

• Hospital Pharmacies
• Retail & Online Pharmacies

COMPANIES PROFILED

• Novo Nordisk AS, Medtronic, Ypsomed AG, Emperra GmbH, Pendiq, Jiangsu Deflu Medical Device Co, Cambridge Consultants Ltd, Diabnext
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SMART INSULIN PENS MARKET: BY CONNECTIVITY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Connectivity
• 4.2. Bluetooth Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Near Field Communication (NFC) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SMART INSULIN PENS MARKET: BY INDICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Indication
• 5.2. Type 1 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Type 2 Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SMART INSULIN PENS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail & Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SMART INSULIN PENS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Connectivity
  • 7.2.2 By Indication
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Connectivity
  • 7.3.2 By Indication
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Connectivity
  • 7.4.2 By Indication
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Connectivity
  • 7.5.2 By Indication
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Connectivity
  • 7.6.2 By Indication
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SMART INSULIN PENS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Novo Nordisk A/S
  • 9.2.2 Medtronic
  • 9.2.3 Ypsomed AG
  • 9.2.4 Emperra GmbH
  • 9.2.5 Pendiq
  • 9.2.6 Jiangsu Deflu Medical Device Co
  • 9.2.7 Cambridge Consultants Ltd
  • 9.2.8 Diabnext